Literature DB >> 2887658

Carbostyril derivatives having potent beta-adrenergic agonist properties.

J Milecki, S P Baker, K M Standifer, T Ishizu, Y Chida, J W Kusiak, J Pitha.   

Abstract

Derivatives carrying a substituent in the para position of the phenyl group of 8-hydroxy-5-[2-[(1-phenyl-2-methylprop-2-yl)amino]-1-hydroxyethyl] carbostyril (10) were prepared and their effects on beta-adrenoceptors evaluated in vitro. Unsubstituted compound 10, iodo 11, amino 12, and bromoacetamido 13 derivatives (all racemic) bound to the receptor with 15-100-fold lower dissociation constants than that of (-)-isoproterenol. All the above compounds stimulated adenylate cyclase more potently than (-)-isoproterenol. The intrinsic activities of compounds 10 and 12 were equal to that of (-)-isoproterenol. The intrinsic activities of compounds 11 and 13 were 1.3 and 1.2 times that of (-)-isoproterenol, respectively. Treatment of membrane preparations with bromoacetamido derivative 13 resulted in an irreversible loss of binding sites, and thus, 13 seems to be an alkylating affinity label for beta-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887658     DOI: 10.1021/jm00392a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Photocytotoxicity of the fluorescent nonsteroidal androgen receptor ligand TDPQ.

Authors:  Piotr J Bilski; Boris Risek; Colin F Chignell; William T Schrader
Journal:  Photochem Photobiol       Date:  2009-05-28       Impact factor: 3.421

2.  Covalent agonists for studying G protein-coupled receptor activation.

Authors:  Dietmar Weichert; Andrew C Kruse; Aashish Manglik; Christine Hiller; Cheng Zhang; Harald Hübner; Brian K Kobilka; Peter Gmeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-08       Impact factor: 11.205

3.  Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitro.

Authors:  K M Standifer; J Pitha; S P Baker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.